We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Jury Hands $142M Win To Kaiser In Neurontin Battle

Law360 (March 26, 2010, 5:12 PM EDT) -- A federal jury has found that Pfizer Inc. improperly marketed its epilepsy drug Neurontin in violation of racketeering and competition laws, awarding plaintiff Kaiser Foundation Health Plan Inc. over $142 million....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.